Search

everythinglearnresearchcommunity

for

Search:↓

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hormones and genes affect hair growth and male baldness.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

PCOS is a major cause of infertility and requires personalized treatment.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

PCOS causes hormonal imbalances, irregular periods, and can lead to infertility, obesity, and mental health issues.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.